News – Page 639 – Endpoints News

FDA adcomm votes unanimously in support of a J&J Covid-19 booster two months after one-dose shot

4 years ago

FDA adcomm to decide on molnupiravir EUA; Cancer atlas unveils new potential drug target

4 years ago

A Bob Nelsen startup turns to Harvard to help sharpen its tech, inspiring first spinout

4 years ago

Incyte yanks EU application for PD-1 drug, citing inability to answer regulators' 'major concerns'

4 years ago

Novartis development chief John Tsai: 'We go deep in the new platforms'

4 years ago

Qiming-backed Abbisko makes $200M+ Hong Kong debut, as a SPAC and Agenus spinout also price on Nasdaq

4 years ago

Pharma veterans regroup with $50M and a plan to discover new multi-specifics

4 years ago

Q&A: Tillman Gerngross explains why his Covid mAb will have an edge over an already crowded field

4 years ago

Imfinzi/tremelimumab combo scores AstraZeneca another OS win — this time in liver cancer

4 years ago

As suits mount, J&J spins out talc liabilities into Chapter 11 using 'Texas two-step' maneuver

4 years ago

Luba Greenwood takes the helm at Kojin Therapeutics, steering an all-female C-suite; Alexion R&D chief packs up for ...

4 years ago

Bayer breaks off Covid-19 vaccine manufacturing pact as CureVac pivots to second-gen work — report

4 years ago

FDA's vaccine adcomm unanimously supports Moderna's booster in same populations as Pfizer's booster

4 years ago

As Moderna's search for African manufacturing site ramps up, Bancel answers criticism about donations

4 years ago

As flu season emerges, BD completes syringe manufacturing lines with help from US government; Hot off summertime ...

4 years ago

Biden likely to nominate Verily's Rob Califf to lead the FDA again

4 years ago

This midwestern CDMO just picked up 3 acquisitions in less than a week

4 years ago

Six years and nearly $1B later, Boehringer Ingelheim's largest ever investment is now operational

4 years ago

A star Stanford professor leaves his lab for a startup out to remake psychiatry

4 years ago

AstraZeneca oncology R&D chief Susan Galbraith: 'You're going to need orthogonal combinations'

4 years ago

Novartis' discovery team hires Genentech vet Shiva Malek to lead early-stage oncology work

4 years ago

Exelixis, Storm join up in collaboration and license agreement; Teligent files for bankruptcy

4 years ago

In the packed oncolytic virus space, a German biotech with a unique approach makes investors reach deeper into their ...

4 years ago

A California biotech steps into the viral vector space with new site build of $75M

4 years ago

First page Previous page 636 637 638639640 641 642 Next page Last page